A detailed history of Steward Partners Investment Advisory, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 9,728 shares of ARDX stock, worth $59,340. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,728
Previous 9,728 -0.0%
Holding current value
$59,340
Previous $71,000 1.41%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$6.05 - $9.74 $48,400 - $77,920
8,000 Added 462.96%
9,728 $71,000
Q1 2022

May 02, 2022

BUY
$0.65 - $1.18 $399 - $725
615 Added 55.26%
1,728 $2,000
Q2 2021

Aug 13, 2021

BUY
$6.55 - $8.98 $7,290 - $9,994
1,113 New
1,113 $8,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $943M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.